Previous studies have reported that vascular disease is associated with glaucoma. However, the relationship between blood pressure (BP) and glaucoma has been inconsistent. We investigated whether there is a nonlinear association between BP and glaucoma in an adult population of the United States.
Original article
Glaucoma is commonly defined as a chronic progressive optic neuropathy characterized by death of retinal ganglion cells. 1 Glaucoma is a major leading cause of blindness and visual impairment worldwide. It is estimated that globally 79.6 million people would have glaucoma by 2020. 2 Glaucoma-induced visual field loss is also associated with the decline in physical and social functions, bodily pain, lower activities of daily living, and mental health. 3, 4 It has been known that intraocular pressure, older age, family history, race, and potential vascular disease increase the risk for glaucoma. [5] [6] [7] [8] However, among vascular risk factors for glaucoma, the relationship between glaucoma and blood pressure (BP) remains inconclusive. 9 Some epidemiologic studies indicated that hypertension or high BP is a possible risk factor for glaucoma. [9] [10] [11] By contrast, some epidemiological studies have shown that lower BP was associated with development and progression of glaucoma. 12, 13 The previous studies seem to be contradictory to each other. However, they may indicate a nonlinear (U-shaped) association between BP and glaucoma. 14 Both low and high levels of BP may increase the risk for glaucoma, but via different physiological mechanisms. High BP can increase intraocular pressure because increased ciliary artery pressure leads to an increased formation of aqueous humor via ultrafiltration. 15 In addition, increased peripheral resistance and small-vessel disease from chronically elevated BP may reduce perfusion in the optic nerve head, leading to retinal ganglion cell loss. 12 On the other hand, low BP can decrease ocular perfusion pressure at the optic nerve head, causing subsequent ischemic damage to retinal ganglion cells. 16, 17 Ocular perfusion pressure can be described as the blood flow to capillary network of the lamina cribrosa region of the optic nerve. 18 Decreased ocular perfusion affects reductions in oxygen delivery to the retina, which may contribute to retinal ganglion cell loss. 19 Few epidemiological studies have investigated a nonlinear relationship between BP and glaucoma. 14 To the best of our knowledge, only 3 studies 12, 13, 20 have explicitly tested a nonlinear relationship between BP and glaucoma. However, the results have been inconclusive. In the Los Angeles Latino Eye Study, 12 a U-shaped relationship with glaucoma was found for diastolic blood pressure (DBP), but not for systolic blood pressure (SBP). But it was the opposite in the Singapore Epidemiology of Eye Diseases Study 20 in which a U-shaped relationship was observed only for SBP. In the Barbados Eye Studies, 13 the incidence of glaucoma was highest in low SBP (≤116 mm Hg) and DBP (≤71 mm Hg), whereas it was similarly lower in medium and high SBP and DBP. In addition, none of the previous studies have examined the association between BP and glaucoma separately in those with and without antihypertensive medications. Thus, the previous studies could not completely rule out the confounding of antihypertensive medications. Further, the previous studies 12, 13, 20 were restricted to Latinos in the Los Angeles area, African descendants in West Indies, and Asians. There is a large difference in the prevalence of glaucoma between different racial and ethnic groups. 21, 22 To the best of our knowledge, no studies have been conducted yet to examine the association between glaucoma and BP in a representative sample of adults in the United States. The objective of this study was to examine whether there is a nonlinear (U-shaped) association between BP and glaucoma. We used the 2005-2008 National Health and Nutrition Examination Survey (NHANES) data including the information on fundus photography examinations and use of antihypertensive medication.
METHODS

Study population
This study was based on the combined data of the Only adults who aged ≥40 years were eligible for the ophthalmological examinations in the NHANESs. From the 7,081 subjects, we excluded those who had not underwent a retinal photograph examination (for details, see later) or those who had underwent the examination, but had no valid image information at least on eye. Then among the remaining 5,536 subjects, we further excluded those with history of ocular operations, such as cataract or near-vision correction (n = 781), or those without valid information on BP were excluded (n = 618). Finally, 4,137 subjects were included for analysis in this study. There were no significant (at the level of P value = 0.05) differences in age, sex, race/ethnicity, education, and family income between the included 4,137 subjects and the excluded 2,944 subjects.
Data collection
The NHANES included a standardized questionnaire administered at home by a trained interviewer and an extensive physical examination in a mobile examination center that included a physical examination, specialized measurements, and laboratory tests.
Assessment of BP
BP for each participant was measured by trained examiners based a standard protocol. 24 After quietly resting in a sitting position for 5 minutes and determining the maximum inflation level, 3 consecutive BP readings were obtained by the auscultatory method using a mercury sphygmomanometer and appropriate cuff size was determined from an upper arm circumference measurement. The second and third readings were used to calculate the mean SBP and DBP values for each participant. 25 Current use of BP-lowering medications was assessed via the question, "Are you now taking prescribed medicine for high blood pressure?"
Glaucoma
Each participant underwent the retinal photographs of macular and optic disc of both eyes. Two 45-degree nonmydriatic digital retinal images of each eye were obtained using an ophthalmic digital imaging system (CR6-45NM camera; Canon USA, Melville, NY). Technicians were trained before the use of the digital imaging system. Initial digital images including cup-to-disc ratio were evaluated at the University of Wisconsin Fundus Photograph Reading Center to determine image quality (excellent, good, fair, poor, ungradable). 26 All images with a cup-to-disc ratio 0.6 or greater on initial grading were reviewed and regarded by 3 glaucoma specialists at the Wilmer Eye Institute of the Johns Hopkins University School of Medicine. They judged the presence of glaucoma in each eye using the appearance of the optic nerve on fundus photography (no, possible, probable, definite, unable). Glaucoma was then defined as probable or definite cases in at least 1 eye. 27 
Covariates
Data regarding participants' age, sex, race/ethnicity, education, and poverty were collected in a demographic questionnaire. Income-to-poverty ratio as a poverty measure is a ratio of family income to the poverty threshold. 22 Participants were asked whether they had a history of cardiovascular disease including a history of angina or heart attack. They were also asked about whether they were taking NHANES used a complex, stratified, multistage probability sampling design that requires a weighting scheme to provide unbiased prevalence estimates representative of the US population. All statistical analyses were performed using these calibrated weights and SPSS complex survey analysis (version 21; SPSS, Chicago, IL) to compensate for the complex multistage probability sampling design. 27 The study sample was divided into the following 2 groups: glaucoma group and non-glaucoma group. The distributions of the study variables (sociodemographic and clinical characteristics) in each of the 2 groups were compared. As in the previous study, 12 both SBP and DBP values were collapsed into categories of 10 and 20 mm Hg, respectively. Also, the reference BP levels were determined as 111-120 mm Hg for SBP and 71-80 mm Hg for DBP. The univariate association between BP and glaucoma was tested with chi-square test. The univariate and multivariate Cox's proportional hazards models [28] [29] [30] [31] were also constructed to investigate the association between glaucoma and BP using the prevalence ratios and their 95% confidence intervals (CIs). Initially, the prevalence ratios and their 95% CIs for having glaucoma were calculated of each BP subgroup (model 1). We extended the initial univariate model by the adjustment for age and sex (model 2). Finally, we examined the multivariate association between BP and glaucoma after controlling for age, sex, race/ ethnicity, diabetes, and antihypertensive medication (model 3). In addition, we replicated the above multivariate analyses by the status of the use of antihypertensive medication.
RESULTS
Of the 4,137 participants in this study, 80 participants (1.2%, 95% CI, 0.9-1.2) had definite or probable glaucoma. The sociodemographic and clinical characteristics of the participants are summarized in Table 1 . There were no significant differences in education, income-to-poverty ratio, and a history of cardiovascular disease between glaucoma and non-glaucoma subjects. However, there were significant differences in age, sex, race/ ethnicity, diabetes, and antihypertensive medication between the 2 groups. Glaucoma subjects, compared to non-glaucoma subjects, were more likely to be older, male, black, with diabetes, and under antihypertensive medications. Table 2 shows the univariate and multivariate associations between SBP and glaucoma. There was a U-shaped relationship between SBP and glaucoma ( Table 2 and Figure 1 ). The prevalence of glaucoma was lowest in the reference group of SBP, 111-120 mm Hg. In the final multivariate model (model 3) after controlling for age, sex, race/ethnicity, diabetes, and antihypertensive medication, glaucoma was 2.32 times more prevalent (95% CI, 0.55-9.78) in those with SBP of ≥161 mm Hg than in the reference group. In addition, glaucoma was more prevalent in those with SBP of ≤110 mm Hg than in the reference group: prevalence ratio (95% CI) = 2.39 (0.80-7.13). On the other hand, the prevalence of glaucoma was very similar between the 2 SBP groups (121-140 and 141-160 mm Hg), although it was slightly higher in those groups than in the reference group. Table 2 also shows the univariate and multivariate associations between DBP and glaucoma. There was also a U-shaped relationship between DBP and glaucoma (Table 2 and Figure 2 ). In the final multivariate model (model 3), when compared to the reference group (71-80 mm Hg), the prevalence of glaucoma was 1.56 times higher (95% CI, 0.56-4.36) in those with DBP of ≥91 mm Hg and 1.15 times higher (95% CI, 0.47-2.81) in those with DBP of ≤60 mm Hg. However, interestingly, the lowest prevalence of glaucoma Abbreviations: CI, confidence interval; BP, blood pressure; DBP, diastolic BP; PR, prevalence ratio; SBP, systolic BP. *P < 0.20; ** P < 0.05; *** P < 0.01 at chi-square test. was observed in those having DBP levels of 81-90 mm Hg, not in the reference group. The aforementioned analyses were replicated after the stratification of data by the status of taking antihypertensive medications. A much clearer U-shaped relationship between SBP and glaucoma was observed in those without antihypertensive medications (Figure 1 ). In the final multivariate model (model 3), when compared to the reference group, the prevalence of glaucoma was 6.42 times higher (95% CI, 1.01-40.81) in those with SBP of ≥161 mm Hg and 5.46 times higher (95% CI, 1.77-16.53) in those with SBP of ≤110 mm Hg (Table 3) . However, there was no association between SBP and glaucoma in those with antihypertensive medications, although the prevalence of glaucoma was lowest in those having SBP levels of ≤110 mm Hg. Similarly, a clearer U-shared relationship between DBP and glaucoma was observed in those without antihypertensive medications (Figure 2 ). The prevalence of glaucoma was 2.24 times higher (95% CI, 0.78-6.44) in those with DBP of ≥91 mm Hg and 1.48 times higher (95% CI, 0.42-5.28) in those with DBP of ≤60 mm Hg (Table 4) . However, there was no such U-shaped relationship between DBP and glaucoma in those with antihypertensive medications. And the prevalence of glaucoma was lowest in those having DBP levels of 81-90 mm Hg, although there was no significant difference in the prevalence of glaucoma across all DBP levels.
DISCUSSION
This study examined a nonlinear relationship between BP and glaucoma in a representative sample of US adults using the 2005-2008 NHANES data. Both high and low levels of BP (≥161 and ≤110 mm Hg for SBP; ≥91 and ≤60 mm Hg for DBP) increased the risk for glaucoma after controlling for age, sex, race/ethnicity, diabetes, and antihypertensive medication in those without antihypertensive medications. And the prevalence of glaucoma was lowest in those with SBP levels of 111-120 mm Hg and DBP levels of 81-90 mm Hg, respectively. However, there was no such U-shaped relationship between BP and glaucoma in those with antihypertensive medications.
Although some previous studies 12, 13 reported a U-shaped relationship between BP and glaucoma, the evidence was Abbreviations: CI, confidence interval; PR, prevalence ratio; SBP, systolic blood pressure. *P < 0.20; ** P < 0.05; *** P < 0.01 at chi-square test. limited to either SBP 13 or DBP. 12 This study is the first study that demonstrated a U-shaped relationship with glaucoma for both SBP and DBP. This study has an important methodological merit over the previous studies in that the BP-glaucoma association was examined separately in those with and without antihypertensive medications. But none of the previous studies have tested the BP-glaucoma association through a stratification analysis by the status of taking antihypertensive medications. This study indicates that a typical statistical adjustment for antihypertensive medications through multivariate analyses (Tables 2) as in the previous studies can fail to detect a substantial difference in the BP-glaucoma association between those with and without antihypertensive medications (Tables 3 and 4) . Future studies should investigate the BP-glaucoma association separately in those with and without antihypertensive medications. On the other hand, in this study, the 2 extreme levels of SBP and DBP were associated with increased risk of glaucoma in those without antihypertensive medications. This provides a good quantitative basis for BP management for the prevention of glaucoma in nonhypertensive middle-aged adults, that is, at least, BP should be managed within the SBP levels of 110-160 mm Hg and the DBP levels of 60-90 mm Hg for the prevention of glaucoma. In addition, more future studies are needed about the optimal BP levels for the least glaucoma risk in nonhypertensive adult populations. In this study, the lowest prevalence of glaucoma was observed in the SBP levels of 111-120 mm Hg; however, the difference in glaucoma prevalence was not substantial between the 3 medium BP levels (111-160 mm Hg). In addition, in this study, the prevalence of glaucoma was lowest in the DBP levels of 81-90 mm Hg, whereas it was lowest in the DBP levels of 71-80 mm Hg in the Los Angeles Latino Eye Study. 12 There was no significant association between BP and glaucoma in those with antihypertensive medications. This cross-sectional study is limited in examining the association between BP and glaucoma because of the following 2 reasons: antihypertensive medications lower BP and some antihypertensive medications (e.g., systemic β1-blockers) may reduce the risk of developing glaucoma. [32] [33] [34] Future prospective studies with detailed information on antihypertensive medications in nonglaucoma subjects are needed.
Recently, the recommended target BP for patients has wavered, and various targets are recommended for different patient populations. 35 For example, the Systolic Blood Pressure Intervention Trial study supported a more aggressive management of SBP (<120 mm Hg vs. the standard treatment, i.e., <140 mm Hg) for the prevention of cardiovascular events and cardiovascular mortality in those aged 50 or more years with SBP levels of ≥130 mm Hg and an increased cardiovascular risk. 36 In addition, the American Heart Association has revised definition of hypertension from 140/90 to 130/80 mm Hg. 37 However, all of the above should be balanced against the evidence in the literature that too low BP damages the optic nerve. 14 The results of this study also support that too low BP levels increase the risk for glaucoma. Due attention should be given to the U-shaped relationship between BP and glaucoma. At the same time, this study supports a more concerted effort between clinicians in internal medicine and ophthalmology for prevention and treatment of glaucoma. 14, 38 The strengths of our study in analyzing the relationship between BP and glaucoma include using a nationwide representative sample of the US population, exclusion of intraocular pressure in the definition of glaucoma, exclusion of errors in BP measurements, controlling for factors such as use of antihypertensive medication and history of cardiovascular diseases, and stratification of participants by specific BP levels. In addition, we relied on fundus photographs for glaucoma identification, whereas most previous studies performed intraocular pressure, visual acuity, or visual field testing for glaucoma diagnosis. [9] [10] [11] Fundus images to identify glaucoma have been widely used in recent glaucoma studies 27 because of their ability to grade the optic nerve including disc size. Also, 3 glaucoma experts independently graded all optic nerve images and made the final diagnosis to minimize interpretation bias and measurement errors. 26, 27 There are 2 limitations in this study. First, the cross-sectional study design precludes the determination of the temporal relationship between BP and glaucoma. Longitudinal studies are warranted in future to confirm the associations observed in this study. Second, we could not distinguish various types of glaucoma in this study, although open-angle glaucoma is the most common type (≥90%). Future studies with detailed information on the type of glaucoma are needed to further elucidate the role of BP in the etiology of glaucoma.
In summary, we found a nonlinear (U-shaped) relationship between BP and the glaucoma in a large representative sample of US adults without antihypertensive medication. Our findings suggest that low BP, as well as high BP, is a significant vascular risk factor for glaucoma. Future longitudinal studies are needed about the BP-glaucoma association and the optimal BP levels for the prevention of glaucoma in general adult populations.
